Compound ID | 1871
Synonym(s): CP-45,899
Class: Beta-lactamase inhibitor
| Agent Type: | Natural product; Small molecule; Direct acting; Antibiotic adjuvant; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Binds irreversibly to beta-lactamases, mainly class A enzymes |
| Target Pathogen: | Active against Acinetobacter baumannii |
| Combined with other compounds: | Yes |
| Description: | Natural product from Streptomyces; only available as a combination product, oral and parenteral application; penicillanic acid sulfone; no intrinsic antibacterial activity except against some Acinetobacter strains |
| Institute where first reported: | Pfizer |
| Year first mentioned: | 1978 |
| Highest development stage: | Approved by FDA in 1986 |
| Development status: | Approved |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/130313 |
| Guide to Pharmacology: | sulbactam |
| Citations: |
|